A. Karnoub and R. Weinberg, Ras oncogenes: split personalities, Nature Reviews Molecular Cell Biology, vol.21, issue.7, pp.517-548, 2008.
DOI : 10.1038/nrm2438

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915522

J. Gibbs, I. Sigal, M. Poe, and E. Scolnick, Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules., Proceedings of the National Academy of Sciences, vol.81, issue.18, pp.5704-5712, 1984.
DOI : 10.1073/pnas.81.18.5704

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC391779

K. Shimizu, M. Goldfarb, Y. Suard, M. Perucho, Y. Li et al., Three human transforming genes are related to the viral ras oncogenes., Proceedings of the National Academy of Sciences, vol.80, issue.8, pp.2112-2118, 1983.
DOI : 10.1073/pnas.80.8.2112

M. Innocenti, P. Tenca, E. Frittoli, M. Faretta, A. Tocchetti et al., Mechanisms through which Sos-1 coordinates the activation of Ras and Rac, The Journal of Cell Biology, vol.270, issue.1, pp.125-161, 2002.
DOI : 10.1083/jcb.200108035

M. Mckay and D. Morrison, Integrating signals from RTKs to ERK/MAPK, Oncogene, vol.13, issue.22
DOI : 10.1074/jbc.M413327200

A. Nimnual, D. Bar-sagi, A. Roberts, T. Araki, K. Swanson et al., The two hats of SOS Germline gain-of-function mutations in SOS1 cause Noonan syndrome, Sci STKE Nat Genet, vol.39, pp.70-74, 2002.

K. Steenland, P. Bertazzi, A. Baccarelli, and M. Kogevinas, Dioxin Revisited: Developments Since the 1997 IARC Classification of Dioxin as a Human Carcinogen, Environmental Health Perspectives, vol.112, issue.13, pp.1265-1273, 2004.
DOI : 10.1289/ehp.7219

A. Okey, An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI, Toxicological Sciences, vol.98, issue.1, pp.5-38, 2007.
DOI : 10.1093/toxsci/kfm096

B. Fukunaga, M. Probst, S. Reisz-porszasz, and O. Hankinson, Identification of functional domains of the aryl hydrocarbon receptor, J Biol Chem, vol.270, pp.29270-29278, 1995.

J. Rowlands and J. Gustafsson, Aryl Hydrocarbon Receptor-Mediated Signal Transduction, Critical Reviews in Toxicology, vol.91, issue.2, pp.109-143, 1997.
DOI : 10.1128/MCB.11.8.4104

/. Nedd9 and . Hef1, Cas-L mediates the effects of environmental pollutants on cell migration and plasticity, Oncogene, 2009.

A. Puga, A. Maier, and M. Medvedovic, The transcriptional signature of dioxin in human hepatoma HepG2 cells, Biochemical Pharmacology, vol.60, issue.8, pp.1129-1171, 2000.
DOI : 10.1016/S0006-2952(00)00403-2

J. Ramos, The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells, The International Journal of Biochemistry & Cell Biology, vol.40, issue.12, pp.2707-2726, 2008.
DOI : 10.1016/j.biocel.2008.04.009

J. Schwanekamp, M. Sartor, S. Karyala, D. Halbleib, M. Medvedovic et al., Genome-wide analyses show that nuclear and cytoplasmic RNA levels are differentially affected by dioxin, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1759, issue.8-9, pp.388-402, 2006.
DOI : 10.1016/j.bbaexp.2006.07.005

F. Frueh, K. Hayashibara, P. Brown, J. Whitlock, and J. , Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression, Toxicology Letters, vol.122, issue.3, pp.189-203, 2001.
DOI : 10.1016/S0378-4274(01)00364-2

A. Marchand, C. Tomkiewicz, J. Marchandeau, E. Boitier, R. Barouki et al., 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Insulin-Like Growth Factor Binding Protein-1 Gene Expression and Counteracts the Negative Effect of Insulin, Molecular Pharmacology, vol.67, issue.2, pp.444-52, 2005.
DOI : 10.1124/mol.104.004010

A. Gomez-duran, J. Carvajal-gonzalez, S. Mulero-navarro, B. Santiago-josefat, A. Puga et al., Fitting a xenobiotic receptor into cell homeostasis: How the dioxin receptor interacts with TGF?? signaling, Biochemical Pharmacology, vol.77, issue.4, pp.700-712, 2009.
DOI : 10.1016/j.bcp.2008.08.032

S. Safe, 3-Methylcholanthrene Induces Differential Recruitment of Aryl Hydrocarbon Receptor to Human Promoters, Toxicological Sciences, vol.117, issue.1, pp.1-3, 2010.
DOI : 10.1093/toxsci/kfq193

S. Margarit, H. Sondermann, B. Hall, B. Nagar, A. Hoelz et al., Structural Evidence for Feedback Activation by Ras??GTP of the Ras-Specific Nucleotide Exchange Factor SOS, Cell, vol.112, issue.5, pp.685-95, 2003.
DOI : 10.1016/S0092-8674(03)00149-1

H. Sondermann, S. Soisson, S. Boykevisch, S. Yang, D. Bar-sagi et al., Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless, Cell, vol.119, issue.3, pp.393-405, 2004.
DOI : 10.1016/j.cell.2004.10.005

Y. Narumi, Y. Aoki, T. Niihori, M. Sakurai, H. Cave et al., Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome, Journal of Human Genetics, vol.9, issue.8, pp.834-875, 2008.
DOI : 10.1007/s10038-008-0320-0

S. Deangelo, J. Murphy, L. Claman, J. Kalmar, and B. Leblebicioglu, Hereditary gingival fibromatosis--a review, Compend Contin Educ Dent, vol.28, issue.44, pp.138-181, 2007.

G. Findlay and T. Pawson, How is SOS activated? Let us count the ways, Nature Structural & Molecular Biology, vol.9, issue.6, pp.538-578, 2008.
DOI : 10.1016/j.molcel.2004.11.054

L. Quilliam, New Insights into the Mechanisms of SOS Activation, Science's STKE, vol.2007, issue.414, p.67, 2007.
DOI : 10.1126/stke.4142007pe67

T. Watanabe, N. Shinohara, K. Moriya, A. Sazawa, Y. Kobayashi et al., Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines, IUBMB Life, vol.49, pp.317-337, 2000.

F. Koizumi, T. Shimoyama, F. Taguchi, N. Saijo, and K. Nishio, Establishment of a human non-small cell lung cancer cell line resistant to gefitinib, International Journal of Cancer, vol.61, issue.1, pp.36-44, 2005.
DOI : 10.1002/ijc.20985